Siemens Healthcare has announced that the Food and Drug Administration (FDA) has cleared the Magnetom Prisma, a 3 Tesla (3T) magnetic resonance imaging (MRI) scanner capable of extraordinarily high spatial and temporal resolution to achieve outstanding image quality, particularly in highly demanding applications.

Following public comment received in the fall of 2013, The Joint Commission has released new accreditation standards for diagnostic imaging services. Nearly all of these new standard Elements of Performance (EP) are slated to become effective in a half-year.

As breast density becomes a more recognized risk factor for breast cancer, Royal Philips announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Spectral Breast Density Measurement Application for its MicroDose SI full-field digital mammography (FFDM) system. The application is the first spectral Breast Density Measurement tool, meaning adipose (fat) and glandular tissue can be differentiated to accurately measure volumetric breast density.

Piramal Imaging announced today the European Union's Committee for Medicinal Products for Human Use (CHMP) recommended approval of NeuraCeq (florbetaben 18F). The CHMP's recommendation will now be referred to the European Commission, for approval in the European Union (EU).

ViewRay Inc., a privately held medical device company, secured $30 million of funds to support the worldwide commercialization of the ViewRay system.

Toshiba America Medical Systems Inc. introduced enhancements to its Vantage Titan magnetic resonance (MR) product line.

Mobius Medical Systems LP announced the release of the latest version of its flagship software product Mobius3D.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now